URICOSURIC ACTION OF HALOFENATE (MK-185) IN PATIENTS WITH HYPERURICEMIA OR UNCOMPLICATED PRIMARY GOUT AND HYPERLIPIDEMIA

被引：14

作者：

HUTCHISON, JC ^{[1
]}

WILKINSON, WH ^{[1
]}

机构：

[1] ABINGTON MEM HOSP, ABINGTON, PA 19001 USA

来源：

关键词：

D O I：

10.1016/0021-9150(73)90065-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：353 / 362

页数：10

相关论文

共 8 条

[1]

DUNCAN DB, 1955, BIOMETRICS MAR

[2]

GILFILLAN JL, 1971, P SOC EXP BIOL MED, V136, P1274

[3]

HUCKER HB, 1971, J PHARMACOL EXP THER, V179, P359

[4]

HUTCHISON JC, TO BE PUBLISHED

[5]

JAIN A, 1970, CLIN PHARMACOL THER, V11, P551

[6]

MORGAN JP, 1971, CLIN PHARMACOL THER, V12, P517

[7] ALTERATIONS OF FACTORS PREDISPOSING TO CORONARY HEART DISEASE [J].

OSTRANDER, LD .

[8]

SIRTORI CR, 1971, J AM OIL CHEM SOC, V48, pA92